Page not found
Search results
-
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
03/08/2021 A monoclonal antibody “cocktail” developed at Vanderbilt University Medical ... University School of Medicine in St. Louis. In cell-culture studies, the researchers determined the ability of monoclonal ... methods for discovering highly potent antiviral human monoclonal antibodies and validating their ability to protect small ...
sommers - 03/08/2021 - 8:39am
-
A protein that can melt tumors discovered at Vanderbilt
... gene expression programs through interaction with Host Cell Factor-1,” was published in the journal eLIFE on Jan. 8. ... noodle-like protein performs important functions in normal human development, and it often becomes reactivated in the deadliest and most ...
sommers - 02/01/2021 - 10:02am
-
Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections
... bacteria. Bachmann is working with the Center for Technology Transfer and Commercialization to explore development for ... Scanning electron microscopy was performed at the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, ...
sommers - 08/19/2020 - 6:47pm
-
Six Vanderbilt technologies earn US patent protection in May
... Compounds and methods useful for directing stem cell differentiation 9,029,563 ...
batesbs - 10/02/2015 - 10:45am
-
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
... their name. The spike protein binds to receptors on human cells and enables virus entry. It is required for infection and is the ... neutralize it to prevent infection. If the mRNA vaccine technology is successful, it might become a routine way to quickly develop ...
sommers - 08/19/2020 - 7:50pm
-
New leadership announced for the Wond’ry
... engineering management, Peabody College of education and human development as professor of the practice of teaching and learning, and ... while working in close partnership with the Center for Technology Transfer and Commercialization .” Companies where Owens has ...
sommers - 06/12/2019 - 8:35am
-
VUMC-led team isolates antibody that blocks bird flu
... transmitted from birds to humans. In the journal Cell Host & Microbe , James Crowe Jr., MD, and colleagues report that human monoclonal antibodies, isolated from two survivors of H7N9 infections and ...
sommers - 12/16/2019 - 10:57am
-
Vanderbilt receives $20 million from The William K. Warren Foundation to further treatments for brain disorders
... various cognitive diseases. It recently went into human phase-1 FDA clinical trials—a unique accomplishment for an academic ... , interim chancellor and provost, as well as a leading cell biologist. “We are honored by the Warren family’s multigenerational ...
sommers - 05/06/2020 - 12:38pm
-
Researchers developing potential Coronavirus antibody therapies
... in humans. “Our goal is to prepare antibodies for human clinical trials by this summer,” said James Crowe , MD, director of ... academic partners in the effort to identify and validate anti-SARS-CoV2 human antibodies include: Helen Chu, MD, MPH, assistant ...
sommers - 03/26/2020 - 1:36pm
-
Antibody isolated at VUMC found to halt dengue virus
... University Medical Center that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and ... they are generated by fusing antibody-producing white blood cell clones to myeloma (cancer) cells to create fast-growing “hybridomas.” ...
sommers - 01/24/2020 - 9:07am